Mechanisms involved in antibody- and complement-mediated allograft rejection

Immunologic Research

Volumn 47, Issue 1-3, 2010, Pages 25-44

  Wasowska, Barbara A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alloantibody; C4d; Cardiac rejection; Complement; Endothelial cells; Fc and complement receptors; Ig knockout mice; Macrophages; MBL; vWf

Indexed keywords

ALLOANTIBODY; ANTIBODY; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C4D; FC RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN M; MANNOSE BINDING LECTIN; PADGEM PROTEIN; VON WILLEBRAND FACTOR;

ALLOGRAFT; ALLOTRANSPLANTATION; COMPLEMENT ACTIVATION; DISEASE MARKER; DRUG BINDING; EFFECTOR CELL; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; EXPERIMENTAL ANIMAL; GRAFT RECIPIENT; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; KNOCKOUT MOUSE; MACROPHAGE; MONOCYTE; NONHUMAN; ORGAN TRANSPLANTATION; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; THROMBOCYTE AGGREGATION; TISSUE INJURY; ANIMAL; C57BL MOUSE; DISEASE MODEL; IMMUNOLOGY; MOUSE; PATHOLOGY;

ANIMALS; COMPLEMENT ACTIVATION; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; ISOANTIBODIES; MACROPHAGES; MICE; MICE, INBRED C57BL; MONOCYTES;

EID: 77953958380     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-009-8136-3     Document Type: Review

References (154)

1. R Patel PI Terasaki 1969 Significance of the positive crossmatch test in kidney transplantation N Engl J Med 280 735 739 4886455
2. HE Feucht E Felber MJ Gokel G Hillebrand U Nattermann C Brockmeyer, et al. 1991 Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection Clin Exp Immunol 86 464 470 1747954
3. SR Lederer H Schneeberger E Albert JP Johnson R Gruber W Land, et al. 1996 Early renal graft dysfunction. The role of preformed antibodies to DR-typed lymphoblastoid cell lines Transplantation 61 213 219
4. WM Baldwin III SK Pruitt RB Brauer MR Daha F Sanfilippo 1995 Complement in organ transplantation: contribution to inflammation, injury and rejection Transplantation 59 797 808 7701572
5. RN Smith N Brousaides L Grazette S Saidman M Semigran T Disalvo, et al. 2005 C4d deposition in cardiac allografts correlates with alloantibody J Heart Lung Transpl 24 1202 1210
6. RN Smith T Kawai S Boskovic O Nadazdin DH Sachs AB Cosimi, et al. 2006 Chronic antibody mediated rejection of renal allografts: pathological, serological and immunologic features in nonhuman primates Am J Transpl 6 1790 1798
7. S Uehara CM Chase LD Cornell JC Madsen PS Russell RB Colvin 2007 Chronic cardiac transplant arteriopathy in mice: relationship of alloantibody, C4d deposition and neointimal fibrosis Am J Transpl 7 57 65
8. J Wehner CN Morrell T Reynolds ER Rodriguez WM Baldwin 3rd 2007 Antibody and complement in transplant vasculopathy Circ Res 100 191 203 17272820
9. S Jordan 2006 IVIG vs. plasmapheresis for desensitization: which is better? Am J Transpl 6 1510 1511
10. SC Jordan AA Vo A Peng M Toyoda D Tyan 2006 Intravenous gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients Am J Transpl 6 459 466
11. Montgomery RA, Cooper M, Kraus E, Rabb H, Samaniego M, Simpkins CE et al. Renal transplantation at the Johns Hopkins Comprehensive Transplant Center. Clin Transpl. 2003:199-213.
12. RA Montgomery AA Zachary 2004 Transplanting patients with a positive donor-specific crossmatch: a single center's perspective Pediatr Transpl 8 535 542
13. RA Montgomery AA Zachary LC Racusen MS Leffell KE King JF Burdick, et al. 2000 Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients Transplantation 70 887 895 11014642
14. M Haas RA Montgomery DL Segev MH Rahman LC Racusen SM Bagnasco, et al. 2007 Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts Am J Transpl 7 576 585
15. DS Warren AA Zachary CJ Sonnenday KE King M Cooper LE Ratner, et al. 2004 Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers Am J Transpl 4 561 568
16. M Haas MH Rahman LC Racusen ES Kraus SM Bagnasco DL Segev, et al. 2006 C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings Am J Transpl 6 1829 1840
17. AH Tang JL Platt 2007 Accommodation of grafts: implications for health and disease Hum Immunol 68 645 651 17678718
18. JL Platt 2002 C4d and the fate of organ allografts J Am Soc Nephrol 13 2417 2419 12191987
19. RJ Lynch JL Platt 2008 Accommodation in organ transplantation Curr Opin Organ Transpl 13 165 170
20. HE Feucht G Opelz 1996 The humoral immune response towards HLA class II determinants in renal transplantation Kidney Int 50 1464 1475 8914011
21. AB Collins EE Schneeberger MA Pascual SL Saidman WW Williams N Tolkoff, et al. 1999 Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries J Am Soc Nephrol 10 2208 2214 10505698
22. LC Racusen RB Colvin K Solez MJ Mihatsch PF Halloran PM Campbell, et al. 2003 Antibody-mediated rejection criteria-an addition to the banff 97 classification of renal allograft rejection Am J Transpl 3 708 714
23. HE Feucht 2003 Complement C4d in graft capillaries-the missing link in the recognition of humoral alloreactivity Am J Transpl 3 646 652
24. S Mauiyyedi RB Colvin 2002 Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment Curr Opin Nephrol Hypertens 11 609 618 12394606
25. AM Herzenberg JS Gill O Djurdjev AB Magil 2002 C4d deposition in acute rejection: an independent long-term prognostic factor J Am Soc Nephrol 13 234 241 11752043
26. SR Lederer B Kluth-Pepper H Schneeberger E Albert W Land HE Feucht 2001 Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts Kidney Int 59 334 341 11135088
27. PJ Michaels ML Espejo J Kobashigawa JC Alejos C Burch S Takemoto, et al. 2003 Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease J Heart Lung Transpl 22 58 69
28. M Mengel J Bogers JL Bosmans D Seron F Moreso M Carrera, et al. 2005 Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial Am J Transpl 5 1050 1056
29. ER Rodriguez DV Skojec CD Tan AA Zachary EK Kasper JV Conte, et al. 2005 Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers Am J Transpl 5 2778 2785
30. WM Baldwin III NA Flavahan RL Fairchild 2002 Integration of complement and leukocytes in response to allotransplantation Curr Opin Transpl 7 92 99
31. WM Baldwin III CP Larsen RL Fairchild 2001 Innate immune responses to transplants: a significant variable with cadaver donors Immunity 14 369 376 11336682
32. SH Sacks P Chowdhury W Zhou 2003 Role of the complement system in rejection Curr Opin Immunol 15 487 492 14499254
33. SH Sacks W Zhou 2003 Locally produced complement and its role in renal allograft rejection Am J Transpl 3 927 932 (Pubitemid 36917537)
34. Z Qian BA Wasowska E Behrens JR Brody SS Kadkol DL Cangello, et al. 1999 C6 produced by macrophages contributes to cardiac allograft rejection Am J Pathol 155 1293 1302 10514411 (Pubitemid 29488936)
35. S Nakashima Z Qian S Rahimi BA Wasowska WM Baldwin 3rd 2002 Membrane attack complex contributes to destruction of vascular integrity in acute lung allograft rejection J Immunol 169 4620 4627 12370401
36. S Nakashima TR Soong K Fox-Talbot Z Qian S Rahimi BA Wasowska, et al. 2005 Impact of MHC class II incompatibility on localization of mononuclear cell infiltrates to the bronchiolar compartment of orthotopic lung allografts Am J Transpl 5 694 701
37. JE Marsh CK Farmer S Jurcevic Y Wang MC Carroll SH Sacks 2001 The allogeneic T and B cell response is strongly dependent on complement components C3 and C4 Transplantation 72 1310 1318 11602861
38. JR Pratt SA Basheer SH Sacks 2002 Local synthesis of complement component C3 regulates acute renal transplant rejection Nat Med 8 582 587 12042808
39. K Li H Patel CA Farrar RE Hargreaves SH Sacks W Zhou 2004 Complement regulates the capacity of proximal tubular epithelial cell to stimulate alloreactive T cell response J Am Soc Nephrol 15 2414 2422 15339990
40. BA Wasowska Z Qian DL Cangello E Behrens K Van Tran J Layton, et al. 2001 Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice Transplantation 71 727 736 11330533 (Pubitemid 32377270)
41. S Rahimi Z Qian J Layton K Fox-Talbot WM Baldwin BA Wasowska 2004 Non-complement and complement activating antibodies synergize to cause rejection of cardiac allografts Am J Transpl 4 326 334
42. K Murata K Fox-Talbot Z Qian K Takahashi GL Stahl WM Baldwin BA Wasowska 2007 Synergistic deposition of C4d by complement-activating and non-activating antibodies in cardiac transplants Am J Transpl 7 2605 2614
43. D Brandle J Joergensen G Zenke K Burki RP Hof 1998 Contribution of donor-specific antibodies to acute allograft rejection: evidence from B cell-deficient mice Transplantation 65 1489 1493 9645808
44. PT Jindra A Hsueh L Hong D Gjertson XD Shen F Gao, et al. 2008 Anti-MHC class I antibody activation of proliferation and survival signaling in murine cardiac allografts J Immunol 180 2214 2224 18250428
45. BA Wasowska Z Qian E Behrens D Cangello F Sanfilippo WM Baldwin III 1999 Inhibition of acute cardiac allograft rejection in immunoglobulin-deficient mice Transpl Proc 31 136
46. B Salomon JA Bluestone 2001 Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation Annu Rev Immunol 19 225 252 11244036
47. EF Reed AJ Demetris E Hammond S Itescu JA Kobashigawa NL Reinsmoen, et al. 2006 Acute antibody-mediated rejection of cardiac transplants J Heart Lung Transpl 25 153 159
48. SM Meehan S Limsrichamrern JR Manaligod T Junsanto MA Josephson JR Thistlethwaite 2003 Platelets and capillary injury in acute humoral rejection of renal allografts Hum Pathol 34 533 540 12827606
49. CN Morrell K Murata AM Swaim E Mason TV Martin LE Thompson, et al. 2008 In vivo platelet-endothelial cell interactions in response to major histocompatibility complex alloantibody Circ Res 102 777 785 18296616
50. H Ota K Fox-Talbot W Hu Z Qian F Sanfilippo RH Hruban, et al. 2005 Terminal complement components mediate release of von Willebrand factor and adhesion of platelets in arteries of allografts Transplantation 79 276 281 15699756
51. CN Morrell H Sun AM Swaim WM Baldwin 3rd 2007 Platelets an inflammatory force in transplantation Am J Transpl 7 2447 2454
52. AD Kirk CN Morrell WM Baldwin 3rd 2009 Platelets influence vascularized organ transplants from start to finish Am J Transpl 9 14 22
53. S Saadi RA Holzknecht CP Patte JL Platt 2000 Endothelial cell activation by pore-forming structures: pivotal role for interleukin-1alpha Circulation 101 1867 1873 10769290
54. S Saadi RA Holzknecht CP Patte DM Stern JL Platt 1995 Complement-mediated regulation of tissue factor activity in endothelium J Exp Med 182 1807 1814 7500026
55. F Tedesco M Pausa E Nardon M Introna A Mantovani A Dobrina 1997 The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity J Exp Med 185 1619 1627 9151899
56. J Schulte am Esch II MA Cruz JB Siegel J Anrather SC Robson 1997 Activation of human platelets by the membrane-expressed A1 domain of von Willebrand factor Blood 90 4425 4437 9373253
57. T Bombeli BR Schwartz JM Harlan 1998 Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha J Exp Med 187 329 339 9449713
58. M Yamakuchi NC Kirkiles-Smith M Ferlito SJ Cameron C Bao K Fox-Talbot, et al. 2007 Antibody to human leukocyte antigen triggers endothelial exocytosis Proc Natl Acad Sci USA 104 1301 1306 17229850
59. CJ Lowenstein CN Morrell M Yamakuchi 2005 Regulation of Weibel-Palade body exocytosis Trends Cardiovasc Med 15 302 308 16297768
60. A Celi G Pellegrini R Lorenzet A De Blasi N Ready BC Furie, et al. 1994 P-selectin induces the expression of tissue factor on monocytes Proc Natl Acad Sci USA 91 8767 8771 7522321
61. AS Weyrich TM McIntyre RP McEver SM Prescott GA Zimmerman 1995 Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation J Clin Investig 95 2297 2303 7537762
62. AS Weyrich MR Elstad RP McEver TM McIntyre KL Moore JH Morrissey, et al. 1996 Activated platelets signal chemokine synthesis by human monocytes J Clin Investig 97 1525 1534 8617886
63. KS Kilgore E Schmid TP Shanley CM Flory V Maheswari NL Tramontini, et al. 1997 Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation Am J Pathol 150 2019 2031 9176395
64. J Torzewski R Oldroyd P Lachmann C Fitzsimmons D Proudfoot D Bowyer 1996 Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. A possible initiating event in atherosclerotic lesion formation Arterioscler Thromb Vasc Biol 16 673 677 8963725
65. C-Y Lee S Lotfi-Emran M Erdinc K Murata E Velidedeoglu K Fox-Talbot J Garyu WM Baldwin III BA Wasowska 2007 The involvement of FcR mechanisms in antibody-mediated rejection Transplantation 9 33 43
66. Z Qian FM Jakobs T Pfaff-Amesse F Sanfilippo WM Baldwin 3rd 1998 Complement contributes to the rejection of complete and class I major histocompatibility complex-incompatible cardiac allografts J Heart Lung Transpl 17 470 478
67. R Hattori KK Hamilton RP McEver PJ Sims 1989 Complement proteins C5b-C9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface J Biol Chem 264 9053 9060 2470750
68. KS Kilgore JP Shen BF Miller PA Ward JS Warren 1995 Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1 J Immunol 155 1434 1441 7543521
69. RS Selvan HB Kapadia JL Platt 1998 Complement-induced expression of chemokine genes in endothelium: regulation by IL-1-dependent and -independent mechanisms J Immunol 161 4388 4395 9780217
70. CM Hawrylowicz GL Howells M Feldmann 1991 Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production J Exp Med 174 785 790 1680957
71. G Soslau DA Morgan JS Jaffe I Brodsky Y Wang 1997 Cytokine mRNA expression in human platelets and a megakaryocytic cell line and cytokine modulation of platelet function Cytokine 9 405 411 9199874
72. PL Ey SJ Prowse CR Jenkin 1979 Complement-fixing IgG1 constitutes a new subclass of mouse IgG Nature 281 492 493 114859
73. PL Ey GJ Russell-Jones CR Jenkin 1980 Isotypes of mouse IgG-I. Evidence for 'non-complement-fixing' IgG1 antibodies and characterization of their capacity to interfere with IgG2 sensitization of target red blood cells for lysis by complement Mol Immunol 17 699 710 7432348
74. MS Neuberger K Rajewsky 1981 Activation of mouse complement by monoclonal mouse antibodies Eur J Immunol 11 1012 1016 7327198
75. KD White MB Frank S Foundling FJ Waxman 1996 Effect of immunoglobulin variable region structure on C3b and C4b deposition Mol Immunol 33 759 768 8811071
76. Yokoyama I, Waxman F. Differential susceptibility of immune complexes to release from the erythrocyte CR1 receptor by factor I. Mol Immunol. 1994;31:227-40.
77. CI Bindon G Hale H Waldmann 1988 Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies Eur J Immunol 18 1507 1514 2973413
78. RM Dommett N Klein MW Turner 2006 Mannose-binding lectin in innate immunity: past, present and future Tissue Antigens 68 193 209 16948640
79. ME McMullen ML Hart MC Walsh J Buras K Takahashi GL Stahl 2006 Mannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo Immunobiology 211 759 766 17113913
80. RK Chan SI Ibrahim K Takahashi E Kwon M McCormack A Ezekowitz, et al. 2006 The differing roles of the classical and mannose-binding lectin complement pathways in the events following skeletal muscle ischemia-reperfusion J Immunol 177 8080 8085 17114482
81. R Malhotra MR Wormald PM Rudd PB Fischer RA Dwek RB Sim 1995 Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein Nat Med 1 237 243 7585040
82. SP Berger A Roos MJ Mallat T Fujita JW de Fijter MR Daha 2005 Association between mannose-binding lectin levels and graft survival in kidney transplantation Am J Transpl 5 1361 1366
83. SP Berger A Roos MJ Mallat AF Schaapherder II Doxiadis C van Kooten, et al. 2007 Low pretransplantation mannose-binding lectin levels predict superior patient and graft survival after simultaneous pancreas-kidney transplantation J Am Soc Nephrol 18 2416 2422 17634432
84. N Imai S Nishi B Alchi M Ueno S Fukase M Arakawa, et al. 2006 Immunohistochemical evidence of activated lectin pathway in kidney allografts with peritubular capillary C4d deposition Nephrol Dial Transpl 21 2589 2595
85. S Sund T Hovig AV Reisaeter H Scott O Bentdal TE Mollnes 2003 Complement activation in early protocol kidney graft biopsies after living-donor transplantation Transplantation 75 1204 1213 12717204
86. Erdinc M, Mcgregor A, Lucas DP, Leffell MS, Montgomery RA, Zachary AA, et al. IVIg inhibits C1q- and mannose binding lectin (MBL)-dependent deposition of C4d by human alloantibodies. Am J Transpl. 2008;8(s2):568.
87. AE Fiane T Ueland S Simonsen H Scott K Endresen L Gullestad, et al. 2005 Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation Eur Heart J 26 1660 1665 15821010
88. JN Arnold MR Wormald RB Sim PM Rudd RA Dwek 2007 The impact of glycosylation on the biological function and structure of human immunoglobulins Annu Rev Immunol 25 21 50 17029568
89. P Garred HO Madsen H Marquart TM Hansen SF Sorensen J Petersen, et al. 2000 Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study J Rheumatol 27 26 34 10648014
90. TW Rademacher P Williams RA Dwek 1994 Agalactosyl glycoforms of IgG autoantibodies are pathogenic Proc Natl Acad Sci USA 91 6123 6127 8016124
91. A Bond A Alavi JS Axford BE Bourke FE Bruckner MA Kerr, et al. 1997 A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine J Autoimmun 10 77 85 9080302
92. GA Rook J Steele R Brealey A Whyte D Isenberg N Sumar, et al. 1991 Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy J Autoimmun 4 779 794 1797027
93. RB Parekh RA Dwek BJ Sutton DL Fernandes A Leung D Stanworth, et al. 1985 Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG Nature 316 452 457 3927174
94. C Collins FW Tsui MJ Shulman 2002 Differential activation of human and guinea pig complement by pentameric and hexameric IgM Eur J Immunol 32 1802 1810 12115664
95. JN Arnold MR Wormald DM Suter CM Radcliffe DJ Harvey RA Dwek, et al. 2005 Human serum IgM glycosylation: identification of glycoforms that can bind to mannan-binding lectin J Biol Chem 280 29080 29087 15955802
96. MC Walsh T Bourcier K Takahashi L Shi MN Busche RP Rother, et al. 2005 Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury J Immunol 175 541 546 15972690
97. JC Scornik W Clapp PR Patton WJ Van der Werf AW Hemming AI Reed, et al. 2001 Outcome of kidney transplants in patients known to be flow cytometry crossmatch positive Transplantation 71 1098 1102 11374409
98. ML Arnold T Zacher M Dechant JR Kalden II Doxiadis BM Spriewald 2004 Detection and specification of noncomplement binding anti-HLA alloantibodies Hum Immunol 65 1288 1296 15556679
99. F Kushihata J Watanabe A Mulder F Claas JC Scornik 2004 Human leukocyte antigen antibodies and human complement activation: role of IgG subclass, specificity, and cytotoxic potential Transplantation 78 995 1001 15480164
100. SS Karuppan S Ohlman E Moller 1992 The occurrence of cytotoxic and non-complement-fixing antibodies in the crossmatch serum of patients with early acute rejection episodes Transplantation 54 839 844 1440851
101. Z Qian C Lee K Murata J Liu K Fox-Talbot B Wasowska, et al. 2006 Antibody and complement mediated injury in transplants following sensitization by allogeneic blood transfusion Transplantation 2006 857 864
102. LR Benzaquen A Nicholson-Weller JA Halperin 1994 Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells J Exp Med 179 985 992 8113689
103. KS Kilgore CM Flory BF Miller VM Evans JS Warren 1996 The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells Am J Pathol 149 953 961 8780399
104. HG Rus FI Niculescu M Shin 2001 Role of the C5b-9 complement complex in cell cycle and apoptosis Immunol Rev 180 49 55 11414362
105. RG DiScipio PJ Daffern MA Jagels DH Broide P Sriramarao 1999 A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo J Immunol 162 1127 1136 9916743
106. S Nataf N Davoust RS Ames SR Barnum 1999 Human T cells express the C5a receptor and are chemoattracted to C5a J Immunol 162 4018 4023 10201923
107. IU Schraufstatter K Trieu L Sikora P Sriramarao R DiScipio 2002 Complement c3a and c5a induce different signal transduction cascades in endothelial cells J Immunol 169 2102 2110 12165538
108. IJ Laudes JC Chu M Huber-Lang RF Guo NC Riedemann JV Sarma, et al. 2002 Expression and function of C5a receptor in mouse microvascular endothelial cells J Immunol 169 5962 5970 12421982 (Pubitemid 35299387)
109. H Bian EF Reed 1999 Alloantibody-mediated class I signal transduction in endothelial cells and smooth muscle cells: enhancement by IFN-gamma and TNF-alpha J Immunol 163 1010 1018 10395699
110. SI Reznik A Jaramillo L Zhang GA Patterson JD Cooper T Mohanakumar 2000 Anti-HLA antibody binding to hla class I molecules induces proliferation of airway epithelial cells: a potential mechanism for bronchiolitis obliterans syndrome J Thorac Cardiovasc Surg 119 39 45 10612759
111. MT Millan C Geczy KM Stuhlmeier DJ Goodman C Ferran FH Bach 1997 Human monocytes activate porcine endothelial cells, resulting in increased E-selectin, interleukin-8, monocyte chemotactic protein-1, and plasminogen activator inhibitor-type-1 expression Transplantation 63 421 429 9039934
112. IH Vos DM Briscoe 2002 Endothelial injury: cause and effect of alloimmune inflammation Transpl Infect Dis 4 152 159 12421461
113. DJ Pidwell MJ Heller D Gabler CG Orosz 1995 In vitro stimulation of human endothelial cells by sera from a subpopulation of high-percentage panel-reactive antibody patients Transplantation 60 563 569 7570952
114. R Fredrich M Toyoda LS Czer K Galfayan O Galera A Trento, et al. 1999 The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation Transplantation 67 385 391 10030283
115. PE Harris H Bian EF Reed 1997 Induction of high affinity fibroblast growth factor receptor expression and proliferation in human endothelial cells by anti-HLA antibodies: a possible mechanism for transplant atherosclerosis J Immunol 159 5697 5704 9548514
116. K Narayanan MD Jendrisak DL Phelan T Mohanakumar 2006 HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway Transpl Immunol 15 187 197 16431285
117. K Narayanan B Naziruddin D Phelan T Mohanakumar 2002 Mechanism for in vitro "accommodation" of human aortic endothelial cells by alloantibodies specific for HLA molecules: down regulation of adhesion molecules and over expression of protective genes Hum Immunol 63 10 Suppl S19
118. MP Soares Y Lin J Anrather E Csizmadia K Takigami K Sato, et al. 1998 Expression of heme oxygenase-1 can determine cardiac xenograft survival Nat Med 4 1073 1077 9734404
119. MP Soares MP Seldon IP Gregoire T Vassilevskaia PO Berberat J Yu, et al. 2004 Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation J Immunol 172 3553 3563 15004156
120. N Abdullah J Greenman A Pimendiou KP Topping JR Monson 1999 The role of monocytes and natural killer cells in mediating antibody-dependent lysis of colorectal tumor cells Cancer Immunol Immunother 48 517 524 10602889
121. RP Macdermott GS Nash NS Merkle IJ Weinrieb MJ Bertovich JF Formeister 1980 Further evidence that antibody-dependent and spontaneous cell-mediated cytotoxicity are mediated by different processes or cell types Immunology 41 439 447 6969223
122. AMM Miltenburg ME Meijer-Paape JJ Weening MR Daha LA van Es FJ van der Woude 1989 Induction of antibody-dependent cellular cytotoxicity against endothelial cells by renal transplantation Transplantation 48 681 2799923
123. JG van de Winkel PJ Capel 1993 Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications Immunol Today 14 215 221 8517920
124. RE Schmidt JE Gessner 2005 Fc receptors and their interaction with complement in autoimmunity Immunol Lett 100 56 67 16125792
125. JV Ravetch S Bolland 2001 IgG Fc receptors Annu Rev Immunol 19 275 290 11244038
126. M Daeron 1997 Fc receptor biology Annu Rev Immunol 15 203 234 9143687
127. S Bolland JV Ravetch 1999 Inhibitory pathways triggered by ITIM-containing receptors Adv Immunol 72 149 177 10361574
128. F Nimmerjahn JV Ravetch 2007 Fc-receptors as regulators of immunity Adv Immunol 96 179 204 17981207
129. F Nimmerjahn P Bruhns K Horiuchi JV Ravetch 2005 FcgammaRIV: a novel FcR with distinct IgG subclass specificity Immunity 23 41 51 16039578
130. Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol. 2008;8:34-47.
131. JHA Boot MEJ Geerts LA Aarden 1989 Functional polymorphisms of Fc receptor in human monocyte-mediated cytotoxicity towards erythrocytes induced by murine isotype switch variants J Immunol 142 1217 2492577
132. JV Ravetch JP Kinet 1991 Fc receptors Annu Rev Immunol 9 457 492 1910686
133. HM Dijstelbloem JG van de Winkel CG Kallenberg 2001 Inflammation in immunity: receptors for IgG revisited Trends Immunol 22 510 516 11525942
134. JA Kirby AL Givan BK Shenton D Talbot JL Forsythe TW Lennard, et al. 1990 Renal allograft rejection. Possible involvement of antibody-dependent cell-mediated cytotoxicity Transplantation 50 225 229 2382289
135. CB Marsh MD Wewers LC Tan BH Rovin 1997 Fc(gamma) receptor cross-linking induces peripheral blood mononuclear cell monocyte chemoattractant protein-1 expression: role of lymphocyte Fc(gamma)RIII J Immunol 158 1078 1084 9013945
136. CB Marsh JE Gadek GC Kindt SA Moore MD Wewers 1995 Monocyte Fc gamma receptor cross-linking induces IL-8 production J Immunol 155 3161 3167 7673729
137. Y Sekine K Yasufuku KM Heidler OW Cummings N Van Rooijen T Fujisawa, et al. 2000 Monocyte chemoattractant protein-1 and RANTES are chemotactic for graft infiltrating lymphocytes during acute lung allograft rejection Am J Respir Cell Mol Biol 23 719 726 11104723
138. KC Nadeau H Azuma NL Tilney 1996 Sequential cytokine expression in renal allografts in rats immunosuppressed with maintenance cyclosporine or mycophenolate mofetil Transplantation 62 1363 1366 8932288
139. ME Russell AF Wallace WW Hancock MH Sayegh DH Adams NE Sibinga, et al. 1995 Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection Transplantation 59 572 578 7533347
140. MA Lones LS Czer A Trento D Harasty JM Miller MC Fishbein 1995 Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients J Heart Lung Transpl 14 151 162
141. AB Magil K Tinckam 2003 Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection Kidney Int 63 1888 1893 12675868
142. LP Erwig DC Kluth GM Walsh AJ Rees 1998 Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines J Immunol 161 1983 1988 9712070
143. N Chouchakova J Skokowa U Baumann T Tschernig KM Philippens B Nieswandt, et al. 2001 Fc gamma RIII-mediated production of TNF-alpha induces immune complex alveolitis independently of CXC chemokine generation J Immunol 166 5193 5200 11290803
144. S Latour C Bonnerot WH Fridman M Daeron 1992 Induction of tumor necrosis factor-alpha production by mast cells via Fc gamma R. Role of the Fc gamma RIII gamma subunit J Immunol 149 2155 2162 1387672
145. ZQ Wang AS Bapat RJ Rayanade AS Dagtas MK Hoffmann 2001 Interleukin-10 induces macrophage apoptosis and expression of CD16 (FcgammaRIII) whose engagement blocks the cell death programme and facilitates differentiation Immunology 102 331 337 11298832
146. A Coxon X Cullere S Knight S Sethi MW Wakelin G Stavrakis, et al. 2001 Fc gamma RIII mediates neutrophil recruitment to immune complexes. A mechanism for neutrophil accumulation in immune-mediated inflammation Immunity 14 693 704 11420040
147. VM Abrahams G Cambridge PM Lydyard JC Edwards 2000 Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis Arthritis Rheum 43 608 616 10728755
148. N Shushakova J Skokowa J Schulman U Baumann J Zwirner RE Schmidt, et al. 2002 C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease J Clin Investig 110 1823 1830 12488432
149. V Kumar SR Ali S Konrad J Zwirner JS Verbeek RE Schmidt, et al. 2006 Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice J Clin Investig 116 512 520 16453025
150. Z Bajtay M Jozsi Z Banki S Thiel N Thielens A Erdei 2000 Mannan-binding lectin and C1q bind to distinct structures and exert differential effects on macrophages Eur J Immunol 30 1706 1713 10898508
151. Mcgregor A, Fox-Talbot K, Velidedeoglu E, Baldwin WMI, Wasowska BA. The absence of FcgRIII results in increased pro-inflammatory response in FcgRIII KO cardiac allograft recipients. Am J Transpl. 2009;9(s2):481.
152. KH Park-Min NV Serbina W Yang X Ma G Krystal BG Neel, et al. 2007 FcgammaRIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin Immunity 26 67 78 17239631
153. Clynes R. IVIG therapy: interfering with interferon-gamma. Immunity. 2007;26:4-6.
154. Clynes R. Protective mechanisms of IVIG. Curr Opin Immunol. 2007;19:646-51.